newsfilter
← Latest News
Business Wire·

Edwards Lifesciences Announces CFO Transition Plan

EW

Edwards Lifesciences (NYSE:EW) today announced that Scott Ullem, the company's chief financial officer, has decided to transition from his role by midyear 2026. While the company initiates a selection process to appoint